Baker Bros. Raises Stake in Synageva BioPharma Corp (GEVA) Through Convention of Options

As a new form 4 filing with the Securities and Exchange Commission showed, Julian and Felix BakersBaker Bros Advisors, a fund focused on the biotechnology and healthcare companies, have revealed upping its long stake in Synageva BioPharma Corp (NASDAQ:GEVA). According to the filing, Baker Bros. have purchased close to 29,800 shares of the company at a price of $60.45 apiece. The price, which is much lower in comparison with the current stock price of Synageva BioPharma, was obtained following the conversion of the Non-Qualified Stock Options, held by the fund since 2005. In this way, currently, Baker Bros. owns almost 10.88 million shares of the company.

Synageva BioPharma

Earlier in April, Baker Bros has also converted options to purchase 56,000 shares of Synageva BioPharma Corp (NASDAQ:GEVA) at a price of $65.10 per share, held since 2007. In this way, Baker Bros. has solidified its position as one of the largest shareholders of the company.

The stock of Synageva BioPharma Corp (NASDAQ:GEVA) has surged by around 62% since the beginning of the year, and by 150% over the past year. The company has posted a significant net loss for the first quarter of the year, of $36.4 million, versus $14.5 million for the same period of the last year, while its revenue amounted to $1.6 million. According to a statement Synageva BioPharma Corp (NASDAQ:GEVA) is working on the development of its ARISE drug for Lysosomal Acid Lipase Deficiency treatment and plans to report top-line results from the Phase 3 trial during the third quarter of the year.

Other investors, among the funds we track, hold smaller positions in Synageva BioPharma. Jerome Pfund and Michael Sjostrom‘s Sectoral Asset Management owns 465,145 shares as of the end of March, down by 37% of the quarter. On the other hand, James E. Flynn‘s Deerfield Management and Donald Chiboucis‘ Columbus Circle Investors have initiated stakes in the company during the first quarter, reporting ownership of 317,700 shares and 186,300 shares of Synageva BioPharma Corp (NASDAQ:GEVA) respectively in their latest 13F filings.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Picture Perfect: The 6 Smartphones with the Best Cameras

The 10 Best Countries To Work In the World

A Profitable Day At The Track: 5 Tips For Betting On Horses

Tearing You Apart: 6 Bad Habits That Ruin Relationships

Learning on the Job: The 6 Biggest Mistakes Parents Make

Shopaholics Rejoice: The 12 Biggest Malls in the World

Fright Night: 10 Horror Movies Based on True Stories

Mach Mania: The 10 Fastest Jets in the World

Military Heavyweights: The 10 Countries with the Most Tanks

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

10 Worst Airlines in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!